IDO1-IN-33
IDO1-IN-33 (Compound YC-16) is a IDO1 inhibitor (with an IC50 of 0.18 μM for IDO1 in HeLa cells). IDO1-IN-33 acts as an apo-IDO1 inhibitor by slowly and competitively displacing heme from mature holo-IDO1 and rapidly binding to the heme-binding site of immature apo-IDO1, without altering the expression level of IDO1. IDO1-IN-33 can be used for the research of hepatocellular carcinoma, non-small cell lung cancer, triple-negative breast cancer, and cervical cancer.
For research use only. We do not sell to patients.
- Formula: C25H25ClN4O
- Molecular Weight:432.95
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
IDO1 0.18 μM (IC50) |
IDO1-IN-33 (0.5 μM) potently inhibits IDO1 activity in HeLa cells, with an IC50 of 0.18 ± 0.01 μM, and shows no significant cytotoxicity[1].
IDO1-IN-33 (48 h) potently inhibits IDO1 activity in multiple human tumor cell lines (HepG2, A549, MDA-MB-231), with corresponding IC50 values of 216.25 ± 12.8 nM, 115.9 ± 1.13 nM and 135.25 ± 12.37 nM, respectively, and shows no significant cytotoxicity[1].
IDO1-IN-33 (0.05-0.4 μM; 48 h) does not regulate the expression of IDO1 mRNA in HeLa cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Molecular Weight 432.95
-
Formula C25H25ClN4O
-
SMILES
CCCC(NC(C1=CC=C(Cl)C=C1)=O)C(N=C2)=CN2CCC3=CC=NC4=C3C=CC=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz